These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31204848)

  • 1. Biophysical and chemical stability of surfactant/budesonide and the pulmonary distribution following intra-tracheal administration.
    Chen CM; Chang CH; Chao CH; Wang MH; Yeh TF
    Drug Deliv; 2019 Dec; 26(1):604-611. PubMed ID: 31204848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biophysical activity of animal-derived exogenous surfactants mixed with rifampicin.
    Kolomaznik M; Calkovska A; Herting E; Stichtenoth G
    Adv Exp Med Biol; 2015; 839():31-9. PubMed ID: 25252905
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of cholesterol and budesonide on biophysical properties of clinical surfactant.
    Zhang H; Wang YE; Neal CR; Zuo YY
    Pediatr Res; 2012 Apr; 71(4 Pt 1):316-23. PubMed ID: 22391630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of budesonide and salbutamol on surfactant properties.
    Palmer D; Schürch S; Belik J
    J Appl Physiol (1985); 2000 Sep; 89(3):884-90. PubMed ID: 10956330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
    Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naturally derived commercial surfactants differ in composition of surfactant lipids and in surface viscosity.
    Rüdiger M; Tölle A; Meier W; Rüstow B
    Am J Physiol Lung Cell Mol Physiol; 2005 Feb; 288(2):L379-83. PubMed ID: 15501950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations.
    Seeger W; Grube C; Günther A; Schmidt R
    Eur Respir J; 1993 Jul; 6(7):971-7. PubMed ID: 8370446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome.
    Speer CP; Gefeller O; Groneck P; Laufkötter E; Roll C; Hanssler L; Harms K; Herting E; Boenisch H; Windeler J
    Arch Dis Child Fetal Neonatal Ed; 1995 Jan; 72(1):F8-13. PubMed ID: 7743295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Note: dissolution of aerosol particles of budesonide in Survanta, a model lung surfactant.
    Pham S; Wiedmann TS
    J Pharm Sci; 2001 Jan; 90(1):98-104. PubMed ID: 11064383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute effects on systemic circulation after intratracheal instillation of Curosurf or Survanta in surfactant-depleted newborn piglets.
    Moen A; Yu XQ; Almaas R; Curstedt T; Saugstad OD
    Acta Paediatr; 1998 Mar; 87(3):297-303. PubMed ID: 9560037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biophysical and physiological properties of a modified porcine surfactant enriched with surfactant protein A.
    Sun B; Curstedt T; Lindgren G; Franzén B; Alaiya AA; Calkovská A; Robertson B
    Eur Respir J; 1997 Sep; 10(9):1967-74. PubMed ID: 9311487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Properties of modified natural surfactant after exposure to fibrinogen in vitro and in an animal model of respiratory distress syndrome.
    Calkovska A; Linderholm B; Haegerstrand-Björkman M; Curstedt T
    Pediatr Res; 2012 Sep; 72(3):262-9. PubMed ID: 22691953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lung preservation in experimental ischemia/reperfusion injury and lung transplantation: a comparison of natural and synthetic surfactants.
    Knudsen L; Boxler L; Mühlfeld C; Schaefer IM; Becker L; Bussinger C; von Stietencron I; Madershahian N; Richter J; Wahlers T; Wittwer T; Ochs M
    J Heart Lung Transplant; 2012 Jan; 31(1):85-93. PubMed ID: 22153552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: A network meta-analysis of randomized controlled trials.
    Zhang L; Cao HY; Zhao S; Yuan LJ; Han D; Jiang H; Wu S; Wu HM
    Pulm Pharmacol Ther; 2015 Oct; 34():46-54. PubMed ID: 26296793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison efficacy of Curosurf and Survanta in preterm infants with respiratory distress syndrome.
    Mirzarahimi M; Barak M
    Pak J Pharm Sci; 2018 Mar; 31(2):469-472. PubMed ID: 29618436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of dynamic surface properties of therapeutic surfactants and lung phospholipids.
    Banerjee R; Puniyani RR; Bellare JR
    J Biomater Appl; 2000 Oct; 15(2):140-59. PubMed ID: 11081642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Superoxide dismutase and catalase activity in naturally derived commercial surfactants.
    Dani C; Buonocore G; Longini M; Felici C; Rodriguez A; Corsini I; Rubaltelli FF
    Pediatr Pulmonol; 2009 Nov; 44(11):1125-31. PubMed ID: 19830697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in vivo characterization of poractant alfa supplemented with budesonide for safe and effective intratracheal administration.
    Ricci F; Catozzi C; Ravanetti F; Murgia X; D'Aló F; Macchidani N; Sgarbi E; Di Lallo V; Saccani F; Pertile M; Cacchioli A; Catinella S; Villetti G; Civelli M; Amadei F; Stellari FF; Pioselli B; Salomone F
    Pediatr Res; 2017 Dec; 82(6):1056-1063. PubMed ID: 28723887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commercial versus native surfactants. Surface activity, molecular components, and the effect of calcium.
    Bernhard W; Mottaghian J; Gebert A; Rau GA; von Der HARDT H; Poets CF
    Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1524-33. PubMed ID: 11029372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Developing an exogenous pulmonary surfactant-glucocorticoids association: Effect of corticoid concentration on the biophysical properties of the surfactant.
    Cimato A; Facorro G; Martínez Sarrasague M
    Respir Physiol Neurobiol; 2018 Jan; 247():80-86. PubMed ID: 28963086
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.